O-Shot & Ultra Femme 360: Intimate Wellness Science
Expert Insights

O-Shot & Ultra Femme 360: Intimate Wellness Science

Dr. Fong breaks down the science behind O-Shot PRP injections and Ultra Femme 360 RF therapy — mechanism, clinical evidence, and candidacy criteria for intimate rejuvenation.

March 19, 2026
SkinArtMD team
Medically reviewed by Dr. Charles Jiang
Back to Insights

O-Shot & Ultra Femme 360: The Science of Intimate Rejuvenation

The conversation around women's intimate health has evolved considerably in recent years. Physician-led clinics like SkinArtMD in Burnaby now offer evidence-informed regenerative treatments — notably the O-Shot (Orgasm Shot) and Ultra Femme 360 — that address a spectrum of concerns from vaginal laxity to sexual dysfunction through distinct yet complementary biological mechanisms. This article examines the cellular science behind each treatment, the clinical evidence supporting them, and how a qualified physician evaluates candidacy.

What Is the O-Shot? Mechanism of Action

The O-Shot is a regenerative procedure rooted in Platelet-Rich Plasma (PRP) or Platelet-Rich Fibrin (PRF) technology. Blood is drawn from the patient, centrifuged to concentrate platelets and growth factors, and the resulting plasma is injected into specific anatomical structures of the vaginal wall and clitoral complex.

The Growth Factor Cascade

Platelets contain a dense library of bioactive proteins central to the O-Shot's mechanism:

  • Platelet-Derived Growth Factor (PDGF): Stimulates fibroblast proliferation and collagen synthesis
  • Vascular Endothelial Growth Factor (VEGF): Promotes neovascularization — the formation of new blood vessels
  • Transforming Growth Factor-β (TGF-β): Modulates extracellular matrix remodeling and suppresses aberrant scar formation
  • Epidermal Growth Factor (EGF): Accelerates epithelial cell turnover and surface regeneration

When injected into the anterior vaginal wall and periclitoral tissue, this concentrated growth factor environment may help restore tissue trophicity lost to estrogen decline, improve local vascularization to potentially enhance sensitivity, and strengthen connective tissue support — with emerging evidence suggesting benefit for mild stress urinary incontinence.

Because the procedure is autologous — using the patient's own blood — immunogenicity risk is negligible, making the O-Shot one of the more physiologically low-risk regenerative applications available in intimate wellness medicine.

Ultra Femme 360: Radiofrequency-Driven Collagen Remodeling

Learn more about Ultra Femme 360

Ultra Femme 360 operates through a fundamentally different mechanism: radiofrequency (RF) thermal energy delivery. The device emits controlled RF waves that penetrate the vaginal mucosa and submucosal layers, raising tissue temperature to the therapeutic threshold (approximately 40–45°C) required to trigger collagen denaturation and subsequent neocollagenesis.

The Thermal Remodeling Sequence

  1. Thermal effect phase: RF energy creates a controlled, precise thermal effect in the dermis and subdermal stroma
  2. Acute inflammatory response: Mast cell degranulation and cytokine release (IL-1, IL-6, TNF-α) initiate the classical wound-healing cascade
  3. Fibroblast activation: Heat shock proteins activate local fibroblasts to synthesize new Type I and Type III collagen
  4. Collagen maturation: Over weeks to months, new collagen fibers reorganize and replace degraded matrix, restoring structural integrity and tissue tone

Ultra Femme 360's 360-degree applicator design delivers uniform circumferential heating, addressing the full vaginal canal rather than focal points — a design consideration that may improve consistency of the thermal dose across the treatment area.

Clinical Evidence: What the Research Shows

PRP and the O-Shot in Female Sexual Dysfunction

Runels et al., published in the Journal of Sexual Medicine, conducted early feasibility work demonstrating patient-reported improvements in sexual function following periclitoral PRP injection. While large-scale randomized controlled trials for this specific anatomical application continue to emerge, the underlying platelet biology is supported by decades of robust evidence in wound healing, orthopedics, and dermatology.

Sharif et al., Gynecological Endocrinology, examined autologous PRP for female sexual dysfunction in a prospective cohort, reporting improvements on the Female Sexual Function Index (FSFI) — particularly in the arousal, lubrication, and satisfaction domains. The investigators hypothesized that VEGF-driven neovascularization in periclitoral tissue underlies the observed functional improvements.

Nikolopoulos et al., European Urology Focus, evaluated PRP in the context of genitourinary syndrome of menopause (GSM), finding histological evidence of epithelial regeneration and submucosal vascular proliferation on biopsy specimens at six weeks post-injection — providing direct mechanistic corroboration for patient-reported symptom improvement.

Radiofrequency for Vaginal Rejuvenation

Lalji & Lozanova, Journal of Cosmetic Dermatology, published a clinical assessment of RF-based vaginal treatments demonstrating statistically significant improvements in vaginal laxity scores, lubrication, and dyspareunia using validated patient-reported outcome measures.

Karcher & Sadick, Dermatologic Surgery, reviewed energy-based devices for vulvovaginal rejuvenation and concluded that RF modalities showed the most consistent histological evidence of neocollagenesis compared to other energy platforms reviewed — providing objective tissue-level confirmation of the remodeling effect.

Note: The intimate wellness evidence base is actively evolving. At SkinArtMD in Burnaby, treatment protocols are reviewed regularly against emerging peer-reviewed data. Patients are encouraged to discuss the current state of evidence with Dr. Fong during consultation.

O-Shot vs. Ultra Femme 360: Side-by-Side Comparison

Swipe left/right to view the full table
FeatureO-Shot (PRP/PRF)Ultra Femme 360 (RF)
MechanismGrowth factor-driven tissue regenerationThermal collagen remodeling
Primary targetSensitivity, sexual function, mucosal healthVaginal laxity, structural tone
Procedure typeInjectableNon-invasive energy device
Typical sessions1–33–4
Onset of effectWeeks (cellular regeneration)Weeks to months (collagen maturation)
DowntimeMinimal (hours)None
AutologousYes — patient's own bloodN/A
Regulatory statusAutologous biologic (off-label intimate application)Health Canada-cleared device

These two treatments are frequently used in combination — RF remodeling restores structural architecture and tone while O-Shot PRP growth factors target functional sensitivity and mucosal regeneration. Dr. Sharon Fong, a CPSBC-registered physician at SkinArtMD, evaluates each patient individually to determine whether monotherapy or a combination protocol is most clinically appropriate.

Book a Consultation to discuss which approach aligns with your goals.

Candidate Evaluation: Who Is a Good Candidate?

Candidate assessment for intimate rejuvenation requires a thorough clinical evaluation — not a checkbox exercise. At SkinArtMD in Burnaby, Dr. Fong's intake process includes a detailed sexual health history, gynecologic history, medication review, and targeted physical assessment.

Presentations That May Benefit

For O-Shot:

  • Decreased sexual arousal or sensitivity not adequately explained by psychological factors alone
  • Genitourinary syndrome of menopause (GSM): dryness, epithelial thinning, recurrent discomfort
  • Mild to moderate stress urinary incontinence
  • Lichen sclerosus as adjunct to standard dermatologic management (emerging evidence)
  • Female sexual arousal disorder in patients who have not responded adequately to conservative management

For Ultra Femme 360:

  • Vaginal laxity following childbirth or aging
  • Mild pelvic floor insufficiency without prolapse
  • Dryness and atrophy-related dyspareunia in patients seeking non-hormonal options
  • General vaginal rejuvenation in the perimenopausal or postmenopausal patient

Contraindications and Exclusion Criteria

Patients who may not be candidates include those with:

  • Active genital infection (bacterial vaginosis, candidiasis, STIs) — must be treated and cleared first
  • Active malignancy or history of gynecologic cancer — requires oncology clearance before proceeding
  • Pregnancy or breastfeeding
  • Severe pelvic organ prolapse (POP Grade III/IV) — surgical consultation is more appropriate
  • Significant uterine or ovarian pathology not yet fully evaluated
  • Platelet dysfunction disorders or anticoagulant therapy — directly relevant to O-Shot candidacy
  • Active implanted electronic devices such as pacemakers or ICDs — relevant for RF-based treatments
  • Significant unaddressed psychosexual comorbidity — best managed in conjunction with appropriate counseling

This evaluation is a clinical prerequisite, not administrative gatekeeping. It is precisely what distinguishes physician-led intimate wellness practice from unqualified providers.

Book a Consultation with Dr. Fong to begin your personalized assessment.

Limitations and Important Considerations

Variable individual response: Results depend on baseline tissue health, degree of hormonal change, procedural technique, and individual regenerative capacity. Individual results vary, and no specific outcome can be guaranteed.

Maintenance may be required: RF collagen remodeling in particular may benefit from periodic maintenance sessions as natural aging continues. The O-Shot may also be repeated to sustain regenerative effects over time.

Not a replacement for systemic therapy: Patients with significant menopausal hormone deficiency may achieve better combined outcomes when intimate rejuvenation is coordinated with appropriate hormonal optimization — such as topical estrogen or bioidentical hormone therapy — under qualified medical supervision.

Evolving evidence base: The mechanistic rationale for both treatments is well-grounded in established tissue biology. Clinical evidence is promising and growing. However, large-scale RCT data specific to intimate applications remains more limited than in some other fields. SkinArtMD presents these treatments within that honest evidence context, because transparency is part of what physician-led care means.

Regulatory note: O-Shot PRP procedures are autologous biologic applications. Ultra Femme 360 uses a Health Canada-cleared device. Regulatory clearance does not constitute a guarantee of individual outcome.

Why Choose SkinArtMD for Intimate Wellness in Burnaby?

Physician-led care at every step. Dr. Sharon Fong is a CPSBC-registered physician with focused training in aesthetics and women's health. Every intimate wellness consultation and treatment at SkinArtMD is physician-supervised — not delegated to support staff or aestheticians operating outside their scope.

Evidence-informed protocols. SkinArtMD uses current-generation RF technology and follows established PRP preparation standards designed to maximize growth factor concentration and procedural consistency.

Personalized treatment plans. Many of our patients in Burnaby arrive with overlapping concerns — laxity, reduced sensitivity, persistent dryness — that may each respond to different modalities. We tailor every plan to the individual rather than defaulting to a single-protocol approach.

Bilingual care. SkinArtMD serves Burnaby's diverse Greater Vancouver community with consultations and patient education available in both English and Mandarin Chinese (普通话). Patients often tell us that being able to discuss intimate health in their preferred language removes a meaningful barrier to seeking care that they had carried for years.

Discreet, respectful clinical environment. Our intake process and clinic space are designed with privacy and comfort in mind. Intimate health deserves the same clinical seriousness as any other medical concern.

Contact us for current pricing — Book a Consultation today.

Frequently Asked Questions

Is the O-Shot painful? Topical numbing cream is applied prior to injection, and the periclitoral region is specifically numbed with local anesthetic to minimize discomfort. Most patients describe the sensation as mild pressure rather than sharp pain. Any post-procedure sensitivity typically resolves within a few hours, and most patients return to normal activities the same day.

How many Ultra Femme 360 sessions will I need? A standard protocol involves 3–4 sessions spaced approximately 1–2 weeks apart, with ongoing collagen maturation continuing for several months after the final session. Some patients with more significant laxity may benefit from additional treatments. Dr. Fong will establish an individualized plan during your consultation.

Can O-Shot and Ultra Femme 360 be combined? Yes — and for many patients, combination therapy may offer complementary benefits. RF remodeling addresses structural laxity and tone while PRP growth factors target mucosal regeneration and sensitivity. Dr. Fong will assess whether a combination or staged approach is appropriate for your specific clinical presentation.

How soon will I see results? Ultra Femme 360 patients often notice initial changes in tone and lubrication within 2–4 weeks of beginning their session series, with ongoing improvement through 3–6 months as new collagen matures. O-Shot responses vary individually; some patients report changes within weeks, while the full regenerative effect may take 2–3 months to manifest.

Are these treatments safe? Both treatments carry favorable safety profiles when performed by qualified physicians. Serious adverse events are rare. Common transient effects after the O-Shot may include mild swelling or spotting. RF treatments involve no downtime. Individual risk profile is assessed thoroughly during the physician consultation before any treatment proceeds.

Are these treatments covered by insurance? Intimate rejuvenation procedures are typically considered elective and are not covered by BC MSP or standard private extended health plans. Contact us for current pricing.

Do I need to stop any medications before treatment? For the O-Shot specifically, patients on anticoagulants or antiplatelet agents should discuss timing with Dr. Fong, as these medications may affect platelet function and treatment efficacy. A complete medication review is conducted as part of the consultation.

Next Steps: Starting Your Intimate Wellness Journey

If you have been researching the O-Shot, Ultra Femme 360, or vaginal rejuvenation options in Burnaby and the Greater Vancouver area, the natural next step is a private consultation with Dr. Fong. She will review your history, conduct an appropriate clinical assessment, and create a personalized treatment plan built around your physiology, your goals, and your timeline. Many patients tell us that having a direct, knowledgeable conversation with a physician removes the uncertainty that had been holding them back for months or years. We understand this is not an easy topic to raise — and we are ready to have that conversation with you.


Ready to See What Ultra Femme 360 and the O-Shot Can Do for You?

Our medical team at SkinArtMD in Burnaby is ready to create your personalized treatment plan. Book your complimentary consultation today — available in English and Chinese.

Limited consultation spots available — reserve yours today.


This article is for educational purposes only and does not constitute medical advice. Please consult with a qualified healthcare professional before undergoing any treatment.

Ready to Get Started?

Book a consultation to discuss your needs with our expert team.

Book a Consultation
Share:

Written by

SkinArtMD team

Ready to Start Your Journey?

Book a complimentary consultation with Dr. Jiang to discuss your personalized treatment plan.

Book Consultation
Schedule your comprehensive skin audit today.

Ready to Curate
Your Narrative?

Take the first step towards your skin and wellness goals. Schedule a comprehensive assessment with our medical team.

Book Consultation
SkinArt MD

Greater Vancouver's premier anti-aging destination. Reshaping natural beauty with state-of-the-art technology and medical artistry.

Social

Contact

Visit Us

Burnaby / Metrotown

4378 Beresford St. #101

Burnaby, BC V5H 0H6

Get Directions

© 2026 SkinArt MD, part of MMC Wellness Group

Designed by Art. Directed by Science.

SKINART